Study of Tumor-Associated Antigens in Cancer Patients
Author Information
Author(s): H. Sakahara, T. Saga, K. Endo, T. Kousaka, M. Hosono, H. Kobayashi, M. Shirato, J. Konishi
Primary Institution: Kyoto University
Hypothesis
Are tumor-associated antigens recognized by different monoclonal antibodies similar and can they be co-expressed?
Conclusion
The study found that certain tumor-associated antigens can be co-expressed on the same molecule, but CEA and CA130 do not co-exist on the same molecule.
Supporting Evidence
- The correlation coefficients for CA125 and CA130 levels and for CA19-9 and SPan1 antigen levels were 0.981 and 0.940, respectively.
- High concentrations of tumor markers were found in the culture supernatants of various cancer cell lines.
- Double determinant assays showed variable binding of antibodies to tumor markers, indicating co-expression.
Takeaway
This study looked at different markers in cancer patients and found that some markers can be found together on the same cancer cells, which helps in understanding cancer better.
Methodology
The study measured concentrations of various tumor markers in cancer cell lines and patient sera using double determinant immunoradiometric assays.
Limitations
The study did not extensively examine the sensitivity or specificity of the new assay systems.
Participant Demographics
Patients included 19 with colon cancer, 16 with pancreatic cancer, and 23 with ovarian cancer.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website